Pricing · March 2026
The first-month number is rarely the number you keep paying
GLP-1 ads in 2026 still lead with a round figure that looks like a subscription. Sometimes that figure is an intake fee. Sometimes it is a compounded starter dose. Sometimes it is a membership that does not include the pen at all. Before you compare two sites, ask which month the price describes and what happens when the dose steps up.
A listing that publishes a floor, such as TrimRx at $149 a month, is easier to audit than a funnel that only reveals cost after a quiz. Still audit it. Maintenance, shipping, and labs can sit outside the headline.
Supply type · April 2026
Compounded GLP-1 is not a cheaper Wegovy or Ozempic
Brand names such as Wegovy®, Ozempic®, and Mounjaro® identify FDA-approved products owned by their manufacturers. Compounded semaglutide or GLP-1 + GIP injections are prepared by a licensed pharmacy and are not FDA-approved copies of those pens. They can be legally available in some settings and still be a different product.
When a 2026 offer says “GLP-1 medication” with no further noun, keep reading. The useful sentence names the pharmacy, the format, and whether a clinician can choose brand-name supply instead. See our trademark disclaimer for how brand names appear on this site.
Follow-up · May 2026
What “unlimited 24/7 support” has to mean to be useful
Chat that is open all night is only a feature if a person who can change the dose sometimes answers it. Nausea on a Saturday, a missed shipment, or a stall at month three are the tests. Programs that staff a clinician loop look different from programs that staff a FAQ bot.
When we score an offer, we look for that loop in the public copy. If it is missing, the monthly price is incomplete even when the number looks low.
Payment · June 2026
HSA and FSA eligibility is not the same as insurance coverage
Cash-pay GLP-1 programs often accept HSA or FSA cards while sitting entirely outside the pharmacy benefit. That can be convenient and still leave you with a denial if you later try to run the same product through insurance. Ask the provider for a receipt category, and ask your plan whether obesity-labeled GLP-1s are covered at all in 2026.
None of this is tax or medical advice. It is a shopping distinction that 2026 ads blur on purpose.